Research Opportunity: Brain enhancement study (BES): Can optimising biochemical parameters (targets) via participation in a multi-modal lifestyle-based intervention improve cognition in amnestic MCI

Mild Cognitive Impairment (MCI) is the stage between the cognitive decline of normal aging and the severe reductions observed in dementia, including Alzheimer’s Disease (AD).

In one year, between 10 to 15% of those with MCI develop AD. Over six years this figure increases to approximately 80%.

Of concern, despite decades of research, no drug has been found to effectively prevent the progression of the disease.

Fortunately, emerging evidence indicates that multi-modal, lifestyle based interventions, may at least stabilise cognition.

Therefore the purpose of this study, by researchers from Avondale University, is to evaluate, in 51 participants, the effectiveness of a 6 month, personalised, lifestyle based, multi-modal intervention to stabilise or improve cognition in those with MCI.

Men and women aged 65 – 80 years old who have memory complaints are invited to apply to participate in the trial.

For more information see Bridging Understanding: Senior-Focused Approaches to Memory Loss.

For further details contact: A/Prof Ross Grant ph: 61 2 49802343 / Dr Jade Berg ph: 61 2 49802344